NCT04743674View on ClinicalTrials.gov

Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

January 15, 2027

Study Completion Date

January 15, 2027

Conditions

Cervical Cancer

Trial Locations (2)

27599

RECRUITING

Melissa Knutsen, Chapel Hill

Unknown

NOT_YET_RECRUITING

Kamuzu Central Hospital, Lilongwe

All Listed Sponsors

lead

UNC Lineberger Comprehensive Cancer Center

OTHER